Brunangelo Falini

Brunangelo Falini Brunangelo Falini is an Italian hematologist, academic and researcher. He is a Full Professor of Hematology, and Head of the Institute of Hematology and Bone Marrow Transplantation at University of Perugia.

Falini serves as a member of the International Lymphoma Study Group (ILSG) and has been in the Clinical Advisory Committees for the WHO classification of lympho-hemopoietic tumors (2001, 2008 and 2017 versions). He has made discoveries in the field of acute myeloid leukemia (AML) and lymphomas, going from bench to bedside. Provided by Wikipedia
Showing 1 - 14 results of 14 for search 'Brunangelo Falini', query time: 0.05s Refine Results
  1. 1
    Pathobiology of ALK-negative anaplastic large cell lymphoma

    Pathobiology of ALK-negative anaplastic large cell lymphoma by Stefano A. Pileri, Claudio Agostinelli, Francesco Bacci, Elena Sabattini, Carlo Sagramoso, Brunangelo Falini, Pier Paolo Piccaluga

    Published 2011-06-01
    Get full text
    Article
  2. 2
    Microenvironmental immune cell alterations across the spectrum of nodular lymphocyte predominant Hodgkin lymphoma and T-cell/histiocyte-rich large B-cell lymphoma

    Microenvironmental immune cell alterations across the spectrum of nodular lymphocyte predominant Hodgkin lymphoma and T-cell/histiocyte-rich large B-cell lymphoma by Christos Panayi, Ayse U. Akarca, Alan D. Ramsay, Ananth G. Shankar, Brunangelo Falini, Miguel A. Piris, David Linch, Teresa Marafioti, Teresa Marafioti

    Published 2023-10-01
    Get full text
    Article
  3. 3
    A Curious Novel Combination of <i>Nucleophosmin</i> (<i>NPM1</i>) Gene Mutations Leading to Aberrant Cytoplasmic Dislocation of <i>NPM1</i> in Acute Myeloid Leukemia (AML)

    A Curious Novel Combination of <i>Nucleophosmin</i> (<i>NPM1</i>) Gene Mutations Leading to Aberrant Cytoplasmic Dislocation of <i>NPM1</i> in Acute Myeloid Leukemia (AML) by Alessandra Venanzi, Roberta Rossi, Giovanni Martino, Ombretta Annibali, Giuseppe Avvisati, Maria Grazia Mameli, Paolo Sportoletti, Enrico Tiacci, Brunangelo Falini, Maria Paola Martelli

    Published 2021-09-01
    Get full text
    Article
  4. 4
    Polatuzumab‐bendamustine‐rituximab as bridge to CD19‐directed CAR T cells in mantle cell lymphoma refractory to ibrutinib and venetoclax

    Polatuzumab‐bendamustine‐rituximab as bridge to CD19‐directed CAR T cells in mantle cell lymphoma refractory to ibrutinib and venetoclax by Vincenzo Maria Perriello, Lorenza Falini, Loredana Ruggeri, Daniele Sorcini, Stelvio Ballanti, Leonardo Flenghi, Nicodemo Baffa, Piero Covarelli, Paolo Sportoletti, Antonio Pierini, Brunangelo Falini

    Published 2023-05-01
    Get full text
    Article
  5. 5
    SiCoDEA: A Simple, Fast and Complete App for Analyzing the Effect of Individual Drugs and Their Combinations

    SiCoDEA: A Simple, Fast and Complete App for Analyzing the Effect of Individual Drugs and Their Combinations by Giulio Spinozzi, Valentina Tini, Alessio Ferrari, Ilaria Gionfriddo, Roberta Ranieri, Francesca Milano, Sara Pierangeli, Serena Donnini, Federica Mezzasoma, Serenella Silvestri, Brunangelo Falini, Maria Paola Martelli

    Published 2022-06-01
    Get full text
    Article
  6. 6
    PB1762: A NEW MONOCLONAL ANTIBODY PROVIDES INSIGHTS ON NPM1 MUTANT SUBCELLULAR EXPRESSION, INTRACLONAL CELL DIFFERENTIATION AND MRD IN NPM1-MUTATED AML

    PB1762: A NEW MONOCLONAL ANTIBODY PROVIDES INSIGHTS ON NPM1 MUTANT SUBCELLULAR EXPRESSION, INTRACLONAL CELL DIFFERENTIATION AND MRD IN NPM1-MUTATED AML by Brunangelo Falini, Maria Paola Martelli, Riccardo Rossi, Fabio Facchetti, Stefania Zini, Erica Borlenghi, Elena Sabbatini, Lorenzo Brunetti, Daniele Sorcini, Vincenzo Perriello, Enrico Tiacci, Bjorn Gjertsen, Vibeke Andresen

    Published 2023-08-01
    Get full text
    Article
  7. 7
    Case Report: Subtotal Lymphoid and Total Marrow Irradiation as Bridge Therapy to CD19-Directed CAR T Cells in a Chemorefractory DLBCL With Leukemic Involvement

    Case Report: Subtotal Lymphoid and Total Marrow Irradiation as Bridge Therapy to CD19-Directed CAR T Cells in a Chemorefractory DLBCL With Leukemic Involvement by Simonetta Saldi, Vincenzo Maria Perriello, Lorenza Falini, Loredana Ruggeri, Christian Fulcheri, Sara Ciardelli, Alessandra Innocente, Stelvio Ballanti, Nicodemo Baffa, Leonardo Flenghi, Antonio Pierini, Cynthia Aristei, Brunangelo Falini

    Published 2022-07-01
    Get full text
    Article
  8. 8
    Management of anaemia in oncohaematological patients treated with biosimilar epoetin alfa: results of an Italian observational, retrospective study

    Management of anaemia in oncohaematological patients treated with biosimilar epoetin alfa: results of an Italian observational, retrospective study by Giovanni Rosti, Mario Petrini, Alberto Bosi, Piero Galieni, Daniele Bernardi, Gianfranco Giglio, Laura Dorotea, Brunangelo Falini, Elvira Scelzi, Enzo Veltri, Roberto Castelli, Chiara Longagnani, Tommaso Raggi, Federico Simonetti

    Published 2017-01-01
    Get full text
    Article
  9. 9
    CD123 Is Consistently Expressed on <i>NPM1</i>-Mutated AML Cells

    CD123 Is Consistently Expressed on <i>NPM1</i>-Mutated AML Cells by Vincenzo Maria Perriello, Ilaria Gionfriddo, Roberta Rossi, Francesca Milano, Federica Mezzasoma, Andrea Marra, Orietta Spinelli, Alessandro Rambaldi, Ombretta Annibali, Giuseppe Avvisati, Francesco Di Raimondo, Stefano Ascani, Brunangelo Falini, Maria Paola Martelli, Lorenzo Brunetti

    Published 2021-01-01
    Get full text
    Article
  10. 10
    NPM1 deletion is associated with gross chromosomal rearrangements in leukemia.

    NPM1 deletion is associated with gross chromosomal rearrangements in leukemia. by Roberta La Starza, Caterina Matteucci, Paolo Gorello, Lucia Brandimarte, Valentina Pierini, Barbara Crescenzi, Valeria Nofrini, Roberto Rosati, Enrico Gottardi, Giuseppe Saglio, Antonella Santucci, Laura Berchicci, Francesco Arcioni, Brunangelo Falini, Massimo Fabrizio Martelli, Constantina Sambani, Anna Aventin, Cristina Mecucci

    Published 2010-01-01
    Get full text
    Article
  11. 11
    Defining TCRγδ lymphoproliferative disorders by combined immunophenotypic and molecular evaluation

    Defining TCRγδ lymphoproliferative disorders by combined immunophenotypic and molecular evaluation by Antonella Teramo, Andrea Binatti, Elena Ciabatti, Gianluca Schiavoni, Giulia Tarrini, Gregorio Barilà, Giulia Calabretto, Cristina Vicenzetto, Vanessa Rebecca Gasparini, Monica Facco, Iacopo Petrini, Roberto Grossi, Nadia Pisanti, Stefania Bortoluzzi, Brunangelo Falini, Enrico Tiacci, Sara Galimberti, Gianpietro Semenzato, Renato Zambello

    Published 2022-06-01
    Get full text
    Article
  12. 12
    Identification of novel STAT5B mutations and characterization of TCRβ signatures in CD4+ T-cell large granular lymphocyte leukemia

    Identification of novel STAT5B mutations and characterization of TCRβ signatures in CD4+ T-cell large granular lymphocyte leukemia by Dipabarna Bhattacharya, Antonella Teramo, Vanessa Rebecca Gasparini, Jani Huuhtanen, Daehong Kim, Jason Theodoropoulos, Gianluca Schiavoni, Gregorio Barilà, Cristina Vicenzetto, Giulia Calabretto, Monica Facco, Toru Kawakami, Hideyuki Nakazawa, Brunangelo Falini, Enrico Tiacci, Fumihiro Ishida, Gianpietro Semenzato, Tiina Kelkka, Renato Zambello, Satu Mustjoki

    Published 2022-02-01
    Get full text
    Article
  13. 13
    Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study

    Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study by Livio Pagano, Marianna Criscuolo, Alessandro Broccoli, Alfonso Piciocchi, Marzia Varettoni, Eugenio Galli, Antonella Anastasia, Maria Cantonetti, Livio Trentin, Sofia Kovalchuk, Lorella Orsucci, Annamaria Frustaci, Angelica Spolzino, Stefano Volpetti, Ombretta Annibali, Sergio Storti, Caterina Stelitano, Francesco Marchesi, Massimo Offidani, Beatrice Casadei, Maria Elena Nizzoli, Maria Lucia De Luca, Luana Fianchi, Marina Motta, Luca Guarnera, Edoardo Simonetti, Andrea Visentin, Francesco Vassallo, Marina Deodato, Chiara Sarlo, Attilio Olivieri, Brunangelo Falini, Alessandro Pulsoni, Enrico Tiacci, Pier Luigi Zinzani

    Published 2022-07-01
    Get full text
    Article
  14. 14
    Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia

    Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia by Farhad Ravandi, Robert J. Kreitman, Enrico Tiacci, Leslie Andritsos, Versha Banerji, Jacqueline C. Barrientos, Seema A. Bhat, James S. Blachly, Alessandro Broccoli, Timothy Call, Dai Chihara, Claire Dearden, Judit Demeter, Sasha Dietrich, Monica Else, Narendranath Epperla, Brunangelo Falini, Francesco Forconi, Douglas E. Gladstone, Alessandro Gozzetti, Sunil Iyengar, James B. Johnston, Jeffrey Jorgensen, Gunnar Juliusson, Francesco Lauria, Gerard Lozanski, Sameer A. Parikh, Jae H. Park, Aaron Polliack, Graeme Quest, Tadeusz Robak, Kerry A. Rogers, Alan Saven, John F. Seymour, Tamar Tadmor, Martin S. Tallman, Constantine S. Tam, Philip A. Thompson, Xavier Troussard, Clive S. Zent, Thorsten Zenz, Pier Luigi Zinzani, Bernhard Wörmann, Kanti Rai, Michael Grever

    Published 2022-12-01
    Get full text
    Article

Search Tools: